SEC Form 4 · accession 0001209191-16-088458
Sagent Pharmaceuticals, Inc. · SGNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathon M Singer
Officer — EVP and CFO
Period of report
Dec 31, 2015
Accepted (ET)
Jan 5, 2016 · 3:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 31, 2015 | F | 853 | $15.85 | D | 24,282 | D |
Table II — derivative securities
No Table II lines on this filing.